fda warning letters glp-1 compounders september 2025 news Compounded versions of tirzepatide (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said FDA and Novo Nordisk Warned

While name-brand GLP-1s typically come in pre-measured auto-injectors, which can be easier to use

Frequently Asked Questions Can GLP-1 receptor agonists replace statins for cholesterol management

Personalized Care Pathways: Every patient's journey is unique

However, Ely Lilly has developed an oral version of the medication, Orforglipron, that the pharmaceutical company plans to submit to the Food & Drug Administration for approval by the end of the year, and for type 2 diabetes treatment in 2026

294 Whether GLP-1-based therapies have any beneficial effects on bone metabolism in humans is currently elusive/unclear

The increased inflammatory response has a direct impact on gingival health meaning you are more likely to have problems with gingivitis and periodontitis. Gingivitis is inflammation of the gums, while periodontitis is a more advanced and destructive form of gum disease